Modifi Biosciences

Modifi Biosciences is a preclinical-stage biotechnology company that has created a new class of molecules designed for oral delivery, aiming to selectively kill cancer cells through direct DNA modification. This technology bypasses the traditional approach of indirectly targeting proteins in cancer cells and has demonstrated potent antitumor activity in cancer cells while sparing normal tissue in laboratory studies. These novel molecules fragment within cells and induce DNA modifications that are irreparable in cancer cells with DNA repair deficiencies.